Efficacy of a Nasal Spray Containing Iota-Carrageenan in the Prophylaxis of COVID-19 Disease in Health Personnel Dedicated to Patients Care With COVID-19 Disease

计划入组 400 人 · 首次发布于 2020 年 8 月 20 日

Iota-Carrageenan Nasal Spray in Common Cold

计划入组 200 人 · 首次发布于 2013 年 9 月 17 日

International Ovarian Tumour Analysis (IOTA) Phase 5

计划入组 15,000 人 · 首次发布于 2012 年 10 月 3 日

iota-Carrageenan

Glycopyranosyl lipid adjuvant (Revelation Biosciences)

Gut-Restricted TGF-Beta Receptor 1 Kinase Inhibitor (Enveda Biosciences)

AURA BIOSCIENCES

India

Assembly Biosciences

United States

EUROMI BIOSCIENCES

France

Iota Biosciences' Implantable Bladder Device Receives FDA IDE Approval for Clinical Trial

FDA Grants Orphan Drug Designation to Pilatus Biosciences' PLT012 for Liver and Bile Duct Cancer

Tyra Biosciences Advances FGFR Inhibitor Pipeline with Multiple Clinical Trials